Parkinson's Disease Trial, Not Yet Recruiting NCT05959161 Sponsor: Tianjin Huanhu Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT05959161
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease for more than 5 years, are under 75 years old, show a meaningful improvement in movement of at least 30% when taking levodopa (a common Parkinson's medication), and have been assessed as suitable for a specific type of brain surgery called deep brain stimulation of the subthalamic nucleus (STN-DBS), with the diagnosis confirmed using a standard set of medical criteria known as the UK Parkinson's Disease Society Brain Bank criteria.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with serious cognitive impairment (significant problems with thinking or memory), severe psychiatric conditions, less than 30% improvement in movement when taking levodopa, a form of parkinsonism that is not standard Parkinson's disease, or any medical reason that would make surgery unsafe or unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Tianjin Huanhu Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2023
Est. completion
1 September 2026

Primary endpoints

motor symptom

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov